Target intelligence / Profile preview

SCP2D1 antisense RNA 1 (SCP2D1-AS1)

Target
SCP2D1-AS1
Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA
01

Overview

SCP2D1 antisense RNA 1 (SCP2D1-AS1) is a transcript of uncertain function belonging to the long noncoding RNA (lncRNA) family. It is transcribed antisense to the SCP2D1 locus but does not encode a protein. Its biological roles, molecular interactions, and potential links to disease are currently unknown. SCP2D1-AS1 is referenced in genomic databases and annotated as a noncoding RNA gene, sometimes as a putative or hypothetical protein due to computational predictions, but experimental evidence does not support protein-coding capacity[3]. There is no indication from available literature or molecular databases that SCP2D1-AS1: - acts as a receptor, transporter, enzyme, or classic drug target - serves any disease role, biomarker, or interacts with drugs - is established as therapeutically actionable If new research elucidates a function, classification or disease association for SCP2D1-AS1, these entries may change. For now, SCP2D1-AS1 is a genomically annotated lncRNA without further characterized molecular function or clinical relevance[3].

Other names
SCP2D1 antisense RNA 1SCP2D1-AS1C20orf78dJ1068E13.1
02

Mechanism of action

Null

03

Biological functions

Other
04

Disease associations

Other

Beyond the preview

Go deeper on SCP2D1 antisense RNA 1 (SCP2D1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCP2D1 antisense RNA 1 (SCP2D1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call